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INTRODUCTION
Malignant schwannomas are tumors that arise 
from the Schwann cells of the peripheral nerves1. They 
represent 10% of all soft-tissue sarcomas, and are rare in the 
head and neck region. The extremities, trunk and thorax are 
the locations most commonly affected. When their origin 
is the paranasal sinuses, the trigeminal nerve is usually 
involved2. The interest in these tumors is their rarity and 
nonspecific symptoms in the nasal cavity. This means that 
they remain unsuspected and are often diagnosed late2,3.
CASE REPORT
A 57-year-old smoker and heavy drinker, who 
was a truck driver, came to the Otorhinolaryngology and 
Head and Neck Surgery Service of Brasília University Hos-
pital presenting nasal obstruction, rhinorrhea and epistaxis 
of three years duration in the right nasal cavity (RNC), 
along with ipsilateral facial pain. Two months earlier, he 
noticed epiphora and exophthalmia in his right eye with 
unaffected visual acuity, but with hearing loss in his right 
ear. Physical examination showed a bent nose, with left axis 
deviation of the nasal septum, and a friable mass inside the 
RNC, showing hemorrhagic spots. Computed tomography 
(CT) on the paranasal sinus revealed a voluminous mass 
in the RNC, extending as far as the pterygopalatine fossa, 
measuring approximately 60 x 70 x 20 mm and eroding the 
medial wall of the maxillary sinus, the lamina papyracea, 
the anterior and posterior ethmoid cells and part of the 
wing of the sphenoid bone (Figure 1A-B).
Endoscopic resection of the mass was attempted 
and a friable brownish lesion with its epicenter probably 
in the posterior ethmoid was seen, along with infiltration 
of adjacent tissue. A biopsy was performed and the histo-
pathological examination revealed a malignant neoplasia 
represented by atypical fusiform cells in a fascicular ar-
rangement, with great alternation of cellularity and areas 
with intense collagen deposition, and with frequent mitotic 
figures and focal areas of necrosis. Immunohistochemical 
analysis showed positivity for the S-100 protein and type 
IV collagen (Figure 1C-D). The histological and immuno-
histochemical findings were compatible with malignant 
tumors of the peripheral nerve sheath.
The patient then underwent another procedure 
to check on the surgical margin status, using an open 
approach via lateral rhinotomy. The orbit was preserved. 
There wasn´t tumor infiltration beyond the margin of 
resection. Postoperative radiotherapy was administered 
to reduce the risk of the disease recurrence. Up to the 
present moment (24 months after the operation), the 
patient has not presented any signs of tumor recurrence 
or distant metastases.
DISCUSSION
Malignant schwannomas are sarcomas that 
arise from Schwann cells of the peripheral nerves. They 
represent approximately 10% of soft-tissue sarcomas, 
and are unusual in the head and neck region (8% of the 
cases)1,2. The most common locations are the extremities, 
trunk, chest and retroperitoneum1,2. Several studies have 
shown that malignant schwannomas in the nasal cavity, 
paranasal sinus and nasopharynx are rare3,4. In the latter 
region, the ethmoid and maxillary sinuses are most often 
affected, the nasal fossa and sphenoid sinus come next 
and the frontal sinus is rarely affected5. There are few 
cases of benign schwannomas in national literature6, just 
Pinto et al.7 cited an unique case of ethmoid malignant 
schwannoma in a study about nasal and paranasal sinuses 
malignant tumors.
Malignant schwannomas of the paranasal sinu-
ses usually originate in the trigeminal nerve, usually from 
the ophthalmic or maxillary division and their terminal 
branches2. Individuals in their fourth and fifth decades 
are more often affected, and there is no preference for 
sex or race1. They can occur alone, but are associated 
with von Recklinghausens disease in 30% of the cases, 
and usually evolve from malignant transformation of 
neurofibroma1,2,5,8.
Microscopically, malignant tumors of the 
peripheral nerve sheath are characterized by layers of 
fusiform cells, with indistinct outlines and a moderate 
amount of cytoplasm. The nuclei are ovoid or fusiform 
with cellular and atypical pleomorphism. The mitotic 
activity level is variable and indicates the aggressiveness 
of the tumor1,3,8. Immunohistochemical analysis is positive 
for the S-100 protein. The differential diagnosis is made 
with fibrosarcoma, malignant fibrous histiocytoma, benign 
schwannoma, capillary hemangioma, hemangiopericyto-
ma and other tumors2,3,8.
The standard treatment consists of resection of 
the tumor with safety margins. Lymph node disease occurs 
infrequently. Distant metastases may involve the lungs, 
and are associated with intracranial invasion3,5. The role 
of radiotherapy and chemotherapy remains controversial. 
However, some authors have indicated radiotherapy in 
cases in which the tumor cannot be completely resected2. 
In the present, we indicated radiotherapy to reduce the 
risk of disease recurrence because it was performed piece 
meal endoscopic resection and histopathological study 
evidenced infiltration of adjacent tissue. The five-year sur-
vival rate is 65.7% among individuals presenting malignant 
schwannoma alone, and falls by 30% when associated with 
type 1 neurofibromatosis. Other prognostic factors include 
the degree of cell pleomorphism, level of mitotic activity 
and size of the primary tumor2,3,8. The present case did 
not present type 1 and presented an excellent result from 
surgery combined with radiation therapy. Currently, the 
patient does not present any signs of tumor recurrence or 
distant metastases.
FINAL COMMENTS
Malignant tumors of the peripheral nerves she-
ath are rare in the head and neck region. The definitive 
diagnosis is only given through histological and immuno-
histochemical evaluations, with positive findings of S-100 
positive. The standard treatment consists of complete 
resection of the tumor, with safety margins.
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Figure 1. Contrast-enhanced axial (A) and coronal (B) computed 
tomography of the paranasal sinus, showing a voluminous mass 
in the right nasal cavity that extended as far as the pterygopalatine 
fossa, with erosion of the medial wall of the maxillary sinus, lamina 
papyracea and anterior and posterior ethmoid cells. Histopatho-
logical examination revealed a malignant neoplasm represented 
by atypical fusiform cells in fascicular arrangement, with great 
alternation of cellularity (HE, 40x) (C). Immunohistochemical 
analysis showed positivity for the S-100 protein (D).
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